Almost none of the ASX’s 2020 listings have been left unscathed by the market panic brought on by the COVID-19 pandemic.

Stockhead’s latest set of data shows that software platform COSOL (ASX:COS) is now the only company with shares still trading above its listing price.

Emerald Clinics (ASX:EMD) is the biggest loser, sinking 80 per cent since its debut in February.

New listings often face a rough time on the market and with the massive sell-offs on the ASX, it’s not surprising that all but one of this year’s listings are now trading below their IPO prices.

Here’s a performance rundown of this year’s ASX entrants:

LISTING DATE TICKER NAME OFFER SIZE OFFER PRICE PRICE (24 MARCH) % RETURN
1/16/2020 NYR Nyrada 9 0.2 0.12 -40
1/23/2020 HVM Happy Valley Nutrition 13 0.2 0.13 -35
1/24/2020 COS COSOL 12 0.2 0.26 30
1/31/2020 CBE Cobre 10 0.2 0.087 -57
12/2/2020 EMD Emerald Clinics 6 0.2 0.04 -80
2/14/2020 TDY Thedocyard 4 0.2 0.095 -53
2/14/2020 CST Castille Resources 20 0.2 0.064 -68
2/20/2020 LGP Little Green Pharma 10 0.45 0.18 -60
2/27/2020 KAU Kaiser Reef 9 0.2 0.15 -25

 

UPCOMING IPOs

The market uncertainty has already claimed its first scalp with technology play Way 2 Vat Ltd withdrawing its $15m IPO.

There are still a number of companies on the ASX’s “pending” list but the coming weeks will be telling on whether these will go ahead or not.

Here’s a list of upcoming IPOs:

TICKER NAME OFFER SIZE ($) OFFER PRICE LISTING DATE
AL3 AML3D 9m 0.2 26 March
AR1 ARMnet 11m 0.2 TBA
AT1 Atomo Diagnostics $30m 0.2 16 April
MHK Metal Hawk $5.5m 0.2 TBA
TNA Tartana Resources $6m 0.2 TBA